Altmetrics
Downloads
194
Views
208
Comments
0
A peer-reviewed article of this preprint also exists.
supplementary.pdf (90.21KB )
Submitted:
27 June 2023
Posted:
28 June 2023
You are already at the latest version
Author (year) | Country | Methods | n | Study period | Age |
---|---|---|---|---|---|
Corcoles et al. (2021) [11] | Spain | RCT | 109 | 4 months | > 65 years |
Guerra et al. (2021) [12] | Brazil | RCT | 118 | 10 months | > 65 and < 75 years |
Lemos et al. (2020) [24] | Brazil | Quasi-experimental | 28 | 9 months | Non-specific |
Rembold et al. (2020) [25] | Brazil | Case control | 239 | 6 years | > 18 years |
Silva et al. (2020) [15] | Brazil | Cohort | 93 | 1 year | > 18 years |
Bjorklund-Lima et al. (2019) [23] | Brazil | Cohort | 50 | 3 months | Non-specific |
Pascoal et al. (2019) [16] | Brazil | Cohort | 136 | 6-10 days | < 5 years |
Silva et al. (2019) [17] | Brazil | Quasi-experimental | 101 | 1 year | > 18 years |
Vázquez-Sánchez et al. (2019) [26] | Spain | RCT | 106 | 4 months | > 18 years |
Gencbas et al. (2018) [13] | Turkey | Pseudo RCT | 62 | Non-specific | Women (non-specific) |
Sampaio et al. (2018) [14] | Portugal | RCT | 74 | 6 months | > 18 and < 65 years |
Pascoal et al. (2016) [18] | Brazil | Cohort | 163 | 6-10 days | Children (non-specific) |
Reis & Jesus (2015) [19] | Brazil | Cohort | 271 | 5 months | Institutionalized elder patients (non-specific) |
Pascoal et al.(2014) [20] | Brazil | Cohortes | 136 | 10 days | < 5 years |
Laguna-Parras et al. (2013) [27] | Spain | Quasi-experimental | 291 | 14 months | > 18 years |
Cárdenas-Valladolid et al. (2012) [21] | Spain | Cohort | 23488 | 2 years | Non-specific |
Müller-Staub et al. (2008) [22] | Switzerland | RCT | 444 | 17 months | Non-specific |
Author (year) | Diagnostic label | Etiologies | Etiology effect measures |
---|---|---|---|
Rembold et al. (2020) [25] | Risk of delayed surgical recovery (00246) | Pain | OR: 3.7 (CI: 2.04–6.65); p<0.001 |
Malnutrition | OR: 8 (CI: 1.96–32.60); p=0.004 | ||
Emotional responses recorded by nurses | OR: 5.2 (CI: 1.26–21.45); p=0.020 | ||
Impaired mobility | OR: 2.6 (CI: 1.42–4.71); p=0.002 | ||
Surgical wound infection | OR: 4.6 (CI: 2.03–10.47); p<0.001 | ||
Preoperative infection of surgical wound | OR: 7.6 (CI: 2.82–20.69); p<0.001 | ||
Prolonged surgical procedure | OR: 2.9 (CI: 1.61–5.20); p<0.001 | ||
Postoperative psychological disorders | OR: 6.4 (CI: 1.23–34.27); p=0.023 | ||
Extensive surgical procedure | OR: 1.8 (CI: 1.04–3.20); p=0.036 | ||
Interoperative complications | OR: 4.81 (CI: 1.55–14.92); p=0.006 | ||
Transfusion | OR: 4.25 (CI: 1.90–9.49); p<0.001 | ||
Anaemia | OR: 3.13 (CI: 1.65–5.93); p<0.001 | ||
Advanced cancer | OR: 2.87 (CI: 1.06–7.77); p=0.032 | ||
Silva et al. (2020) [15] | Dysfunctional ventilatory response to weaning (00034) | Water balance | (Pre) M: 1.64; SD: 13.04. (Post) M: 13.04 SD: 13.14 OR: 1.08 (CI: 1.03-1.12); p=0.000 |
Quantity of antibiotics administered | (Pre) M: 1.02; SD: 1.00 (Post) M: 2.20; SD: 1.17 OR: 2.56 (CI not reported); p=0.000 |
||
Age | (Pre) M: 56.85; SD: 18.48 (Post) M: 65.76; SD: 18.53 OR: 1.03 (CI: 1.00-1.05); p=0.027 |
||
Edema MI | (Pre) M: 1.02; SD: 0.94 (Post) M: 2.39; SD: 1.56 OR: 2.21 (CI: 1.53-3.19); p=0.000 |
||
Edema MS | (Pre) M: 1.23; SD: 1.02 (Post) M: 2.34; SD: 1.56 OR: 1.89 (CI: 1.34-2.66); p=0.000 |
||
Heart rate | (Pre) M: 85.73; SD: 18.07 (Post) M: 96.42 SD: 16.40 OR: 1.04 (CI: 1.01-1.06); p=0.007 |
||
Hemodialysis | (Pre) n=8 (28.6%) (Post) n=20 (71.4%) OR: 5.24 (CI: 1.98-13.83); p=0.000 |
||
Hyperthermia | (Pre) n=5 (22.7%) (Post) n=17 (77.3%) OR: 6.66 (CI: 2.19-20.24); p=0.000 |
||
Oliguria | (Pre) n=5 (16.1%) (Post) n=26 (83.9%) OR: 16.29 (CI: 5.32-49.93); p=0.000 |
||
Clinical severity on admission to ICU (SAPS 3) | (Pre) M: 54.52; SD: 13.13 (Post) M: 64.39; SD: 17.06 OR: 1.04 (CI: 1.01-1.08); p=0.004 |
||
Use of NIV (non-invasive ventilation) after extubation |
(Pre) n=10 (32.3%) (Post) n=21 (67.7%) OR: 4.41 (CI: 1.75-11.09); p=0.002 |
||
Reis & Jesus (2015) [19] | Risk of falls (00155) | History of falls | (Fall) n=59 (85.51%) (No fall) n=145 (71.78%) OR: 2.32 (CI: 1.11-4.85); p=0.025 |
Foot problems | (Fall) n=26 (37.68%) (No fall) n=40 (19.8%) OR: 2.45 (CI: 1.35-4.44); p=0.003 |
||
Polypathology | (Fall) n=19 (25.54%) (No fall) n=24 (11.88%) OR: 2.82 (CI: 1.43-5.56); p=0.002 |
||
Wandering | (Fall) n=46 (66.67%) (No fall) n=100 (49.5%) OR: 2.04 (CI: 1.15-3.61); p=0.014 |
||
Cerebrovascular accident (CVA) | (Fall) n=25 (36.23%) (No fall) n=48 (23.76%) OR: 1.82 (CI: 1.01-3.28); p=0.045 |
Author (year) | Diagnostic label | Defining characteristics | Effect measures of the defining characteristics |
---|---|---|---|
Pascoal et al. (2019) [16] | Impaired gas exchange (00030) | Abnormal skin color | RR: 1.54 (CI: 1.08-2.20); p=0.016 |
Hypoxemia | RR: 135.7 (CI: 75.10-245.19); p<0.001 | ||
Pascoal et al. (2016) [18] | Ineffective airway clearance (00031) | Change in respiratory rate | OR: 2.88 (CI: 1.34-6.19); p=0.007 |
Cyanosis | OR: 0.03 (CI: 0.006-0.19); p<0.001 | ||
Difficulty vocalizing | OR: 10.04 (CI: 2.38-42.35); p=0.002 | ||
Open eyes | OR: 68.73 (CI: 1.53-3086.70); p<0.001 | ||
Adventitious lung sounds | OR: 300.58 (CI: 43.67-2068.86); p<0.001 | ||
Reduced breathing sounds | OR: 9.008 (CI: 2.75-29.48); p<0.001 | ||
Ineffective cough | OR: 129.53 (CI: 33.40-502.19); p<0.001 | ||
Pascoal et al. (2014) [20] | Ineffective respiratory pattern (00032) | Altered respiratory depth | OR: 73.32 (CI: 15.45-347.79); p<0.001 |
Anteroposterior diameter increase | OR: 31.56 (CI: 7.20-138.34); p<0.001 | ||
Altered chest movements | OR: 259.14 (CI: 31.41-2137.92); p<0.001 | ||
Orthopnea | OR: 30.14 (CI: 4.49-202.43); p<0.001 | ||
Tachypnea | OR: 5.89 (CI: 2.02-17.11); p=0.001 | ||
Use of accessory muscles for breathing | OR: 2595.06 (CI: 343.88-19583.3); p<0.001 |
Author (year) | Diagnostic label | Defining characteristics | Effect measures of the defining characteristics |
---|---|---|---|
Pascoal et al. (2019) [16] | Impaired gas exchange (00030) | Abnormal skin color | RR: 1.54 (CI: 1.08-2.20); p=0.016 |
Hypoxemia | RR: 135.7 (CI: 75.10-245.19); p<0.001 | ||
Pascoal et al. (2016) [18] | Ineffective airway clearance (00031) | Change in respiratory rate | OR: 2.88 (CI: 1.34-6.19); p=0.007 |
Cyanosis | OR: 0.03 (CI: 0.006-0.19); p<0.001 | ||
Difficulty vocalizing | OR: 10.04 (CI: 2.38-42.35); p=0.002 | ||
Open eyes | OR: 68.73 (CI: 1.53-3086.70); p<0.001 | ||
Adventitious lung sounds | OR: 300.58 (CI: 43.67-2068.86); p<0.001 | ||
Reduced breathing sounds | OR: 9.008 (CI: 2.75-29.48); p<0.001 | ||
Ineffective cough | OR: 129.53 (CI: 33.40-502.19); p<0.001 | ||
Müller-Staub et al. (2008) [22] | Nurses’ clinical reasoning | NANDA-I | Pre (IG) M: 2.69; SD: 0.9 Post (IG) M: 3.7; SD: 0.54 p<0.0001 |
Pre (CG) M: 3.13; SD: 0.89 Post (CG) M: 2.97: SD: 0.8 p=0.17 | |||
NIC | Pre (IG) M: 2.33: SD: 0.93 Post (IG) M: 3.88; SD: 0.35 p<0.0001 |
||
Pre (CG) M: 2.7; SD: 0.88 Post (CG) M: 2.46; SD: 0.95 p=0.05 | |||
NOC | Pre (IG) M: 1.53; SD: 1.08 Post (IG) M: 3.77; SD: 0.53 p<0.0001 |
||
Pre (CG) M: 2.02; SD: 1.27 Post (CG) M: 1.94; SD: 1.06 p=0.62 |
Author (year) | NNN Interrelationship | Indicator of effectiveness | Effect measure |
---|---|---|---|
Corcoles et al. (2021) [11] | NANDA-I Functional urinary incontinence (00020) NIC Urinary habit training (0600) NOC Urinary continence (0502) |
3 months: Continence |
No: 25.5% (IG) and 47.2% (CG) Yes: 74.5% (IG) and 52.8% (CG) RR=0.54 (CI: 0.31-0.94); p=0.022; NNT: 5 |
3 months: Diurnal incontinence episodes |
(CG) M: 1.54; SD: 2.26 (IG) M: 0.31; SD: 0.76 p=0.002 |
||
3 months: Nocturnal incontinence episodes |
(CG) M: 0.79; SD: 1.29 (IG) M: 0.21; SD: 0.5 p=0.012 |
||
6 months: Continence |
No: 25.5% (IG) and 49% (CG) Sí: 74.5% (IG) and 51% (CG) RR=0.52 (CI: 0.3-0.9); p=0.014; NNT: 4 |
||
6 months: Diurnal incontinence episodes |
(CG) M: 1.8; SD: 2.51 (IG) M: 0.54; SD: 1.46 p=0.007 |
||
6 months: Nocturnal incontinence episodes |
(CG) M: 0.9; SD: 1.47 (IG) M: 0.35; SD: 0.86 p=0.016 |
||
Guerra et al. (2021) [12] | NANDA-I Risk of falls (00155) NIC Fall prevention (6490) |
Decreased incidence of falls | 13.6% reduction in both groups (IG) 6.9% versus (CG) 20.0%; p=0.038 34.48% reduction in relative risk of falls in the IG |
Cause of fall: Difficulty walking | (IG) 0.0% versus (CG) 10.0%; p=0.013 | ||
Place where fall occurred: Living room | (IG) 0.0% versus (CG) 13.3%; p=0.004 | ||
Lemos et al. (2020) [24] | NANDA-I Ineffective health management (00078) NIC
|
Knowledge: heart failure management | (1st assessment) M: 2.05; SD: 0.28 (2nd assessment) M: 2.54; SD: 0.30 (Difference) M: 0.48; SD: 0.21 p=0.002 |
Knowledge: diabetes management | (1st assessment) M: 2.61; SD: 0.55 (2nd assessment) M: 3.21; SD: 0.57 (Difference) M: 0.59; SD: 0.20 p=0.000 |
||
Bjorklund-Lima et al. (2019) [23] | NANDA-I Risk of perioperative postural injury (00087) NOC
|
Measurement at 5 timepoints: mean scores in most NOCs decreased at timepoint 2 (T2-assessment in the operating room at the end of surgery) compared with timepoint 1 (T1-preoperative) | Most NOC showed improvement (p<0.001) in postoperative time score (T3, T4 and T5) compared with T2 |
NOC Consequences of immobility: physiological (0204) | T1 (M: 5.0; SD: 0.0), T2 (M: 4.0; SD: 0.0), T3 (M: 4.24; SD: 0.06), T4 (M: 4.80; SD: 0.05), T5 (M: 4.86; SD: 0.04); p<0.001 | ||
NOC Severity of blood loss (0413) | T1 (M: 4.59; SD: 0.04), T2 (M: 4.59; SD: 0.07), T3 (M: 4.58; SD: 0.09), T4 (M: 4.32 (SD: 4.32; SD: 0.10) T5 (M: 4.45; SD: 0.08); p=0.014 | ||
NOC Circulatory status (0401) | T1 (M: 4.59: SD: 0.06), T2 (M: 4.68; SD: 0.04), T3 (M: 4.41; SD: 0.07), T4 (M: 4.65; SD: 0.06), T5 (M: 4.43; SD: 0.08); p=0.002 | ||
NOC Tissue perfusion: cellular (0416) | T1 (M: 4.94; SD: 0.02), T2 (M: 4.68; SD: 0.05), T3 (M: 4.67; SD: 0.05), T4 (M: 4.68; SD: 0.04), T5 (M: 4.70; SD: 0.04); p<0.001 | ||
NOC Tissue perfusion: peripheral (0407) | T1 (M: 4.92; SD: 0.03), T2 (M: 4.31; SD: 0.09), T3 (M: 4.42; SD: 0.08), T4 (M: 4.58; SD: 0.06), T5 (M: 4.58; SD: 0.08); p<0.001 | ||
NOC Thermoregulation (0800) | T1 (M: 4.69; SD: 0.05), T2 (M: 4.69; SD: 0.05), T3 (M: 4.45; SD: 0.08), T4 (M: 4.86; SD: 0.03), T5 (M: 4.73; SD: 0.05); p<0.001 | ||
NOC Neurological status: peripheral (0917) | T1 (M: 4.96; SD: 0.03), T2 (M: 3.98; SD: 0.18), T3 (M: 4.39; SD: 0.15), T4 (M: 4.65; SD: 0.12), T5 (M: 4.76; SD: 0.11); p<0.001 | ||
NOC Tissue integrity: skin and mucous membranes (1101) | T1 (M: 4.93; SD: 0.02), T2 (M: 4.30; SD: 0.05), T3 (M: 4.50; SD: 0.05), T4 (M: 4.69; SD: 0.04), T5 (M: 4.71; SD: 0.04); p<0.001 | ||
Silva et al. (2019) [17] | NANDA-I Ineffective airway clearance (00031) NIC
Respiratory status (0415) |
NIC Cough enhancement (3250): Respiratory rate |
PR=0.39 (CI: 0.81-0.98); p=0.005 |
NIC Cough enhancement (3250): Adventitious respiratory sounds |
PR=2.20 (CI: 2.55-8.11); p=0.021 | ||
NIC Cough enhancement (3250): Thoracic surgery patients: Improvement in ability to eliminate secretions |
PR=4.55 (CI: 1.13-20.87); p=0.0001 | ||
NIC Cough enhancement (3250): Thoracic surgery patients: Increase in ability to cough |
PR=4.75 (CI: 2.55-8.11); p=0.024 | ||
NIC Cough enhancement (3250): Abdominal surgery patients: Reduction in the presence of dyspnea in mild exertion |
PR=0.38 (CI: 0.62-0.90); p=0.022 | ||
NIC Cough enhancement (3250): Abdominal surgery patients: Decrease in changes in respiratory rate |
PR=0.25 (CI: 0.10-0.60); p=0.001 | ||
NIC Cough enhancement (3250): Abdominal surgery patients: Decrease in nasal flaring |
PR=0.06 (CI: 0.006-0.74); p=0.040 | ||
NIC Cough enhancement (3250): Abdominal surgery patients: Decrease in inspiration depth |
PR=0.45 (CI: 0.21-0.92); p=0.028 | ||
NIC Cough enhancement (3250): Abdominal surgery patients: Improvement in adventitious respiratory sounds |
PR=2.82 (CI: 1.06-7.49); p=0.031 | ||
NIC Ventilation support (3390): Improvement in ability to eliminate secretions |
PR=0.14 (CI: 0.35-0.58); p=0.009 | ||
NIC Ventilation support (3390): Improvement in respiratory rate |
PR=0.43 (CI: 0.19-0.95); p=0.034 | ||
Ventilation support (3390): Improvement in inspiration depth |
PR=0.44 (CI: 0.20-0.97); p=0.040 | ||
NIC Ventilation support (3390): Abdominal surgery patients: Decrease in use of accessory muscles |
PR=0.41 (CI: 0.16-1.007); p=0.046 | ||
NIC Airway management (3140): Decrease in accumulation of sputum |
PR=0.15 (CI: 0.30-0.76); p=0.036 | ||
NIC Airway management (3140): Improvement in adventitious respiratory sounds |
PR=0.14 (CI: 0.24-0.90); p=0.047 | ||
Vázquez-Sánchez et al. (2019) [26] | NANDA-I Nutritional imbalance: lower than body needs (00002) NIC Nutritional assessment (5246) NOC
|
NIC increased NOC indicator score: Prescribed diet | IG: 1.57 vs. CG: 0.22; p<0.001 |
NOC indicator: Prescribed diet | Correlated with BMI (r=-0.34; p=0.001), with Barthel index score (r=0.50; p<0.001) and with MUST questionnaire score (r=0.28; p=0.007) | ||
Intervention increased NOC indicator score NOC: Select foods and liquids compatible with prescribed diet. | IG: 1.20 vs. CG: 0.26; p<0.001 |
||
NOC indicator: Select foods and liquids compatible with prescribed diet | Correlated with BMI score (r=0.34; p=0.001), with Barthel index score (r=0.27; p=0.008) and with MUST questionnaire score (r=-0.22; p=0.018) | ||
Gencbas et al. (2018) [13] | NANDA-I Impaired urinary elimination (00016) NIC
|
In the IG, NIC had the effect of improving all NOC scores following the intervention | |
NIC Urinary bladder training (0570) (n=7) | NOC Urinary continence (Pre) M: 2.93; SD: 3.72 (Post) M: 4.41; SD: 0.24 (Difference) M: 1.48 |
||
NOC Urinary elimination (Pre) M: 3.04; SD: 0.41 (Post) M: 4.49; SD: 0.22 (Difference) M: 1.45 | |||
NIC Urinary elimination management (0590) (n=32) | NOC Self-care: use of the toilet: Pre (M: 3.01; SD: 1.09); Post (M: 4.08; SD: 1.41); Difference M: 1.07 | ||
NOC Urinary continence: Pre (M: 3.24; SD: 0.44); Post (M: 4.44; SD: 0.37); Difference M: 1.2 | |||
NOC Urinary elimination: Pre (M: 3.23; SD: 0.46); Post (M: 4.59; SD: 0.22); Difference M: 1.36 | |||
NIC Urinary habit training (0600) (n=31) | NOC Urinary continence: Pre (M: 3.24; SD: 0.45); Post M: 4.45; SD: 0.37); Difference M: 1.21 | ||
NOC Urinary elimination: Pre (M: 3.22; SD: 0.46); Post (M: 4.58; SD: 0.22); Difference M: 1.36 | |||
NIC Help with self-care: urination/defecation (1804) (n=29) | NOC Self-care: use of the toilet: Pre (M: 3.32; SD: 0.49); Post (M: 4.50; SD: 0.49); Difference M: 1.18 | ||
NOC Urinary continence: Pre (M: 3.20; SD: 0.44); Post (M: 4.43; SD: 0.37); Difference M: 1.23 | |||
NIC Evironmental management (6480) (n=29) | NOC Self-care: use of the toilet: Pre (M: 3.32; SD: 0.49); Post (M: 4.50; SD: 0.49); Difference M: 1.18 | ||
NOC Urinary continence: Pre (M: 3.20; SD: 0.44); Post (M: 4.43; SD: 0.37); Difference M: 1.23 | |||
NOC Urinary elimination: Pre (M: 3.17; SD: 0.44); Post (M: 4.57; SD: 0.22); Difference M: 1.4 | |||
NIC Pelvic floor exercises (0560) (n=32) | NOC Urinary continence: Pre (M: 3.24; SD: 0.44); Post (M: 4.44; SD: 0.37); Difference M: 1.2 | ||
NOC Urinary elimination: Pre (M: 3.23; SD: 0.46); Post (M: 4.59; SD: 0.22); Difference M: 1.36 | |||
NIC Urinary incontinence care (0610) (n=32) | NOC Urinary continence: Pre (M: 3.24; SD: 0.44); Post (M: 4.44; SD: 0.37); Difference M: 1.2 | ||
NOC Urinary elimination: Pre (M: 3.23; SD: 0.46); Post (M: 4.59; SD: 0.22); Difference M: 1.36 | |||
NOC Tissue integrity: skin and mucous membranes: Pre (M: 4.10; SD: 0.75); Post M: 4.93; SD: 0.06); Difference M: 0.83 | |||
NIC Teaching: Prescribed medication (5616) (n=7) | NOC Response to medication: Pre (M: 4.19; SD: 0.81); Post (M: 4.89; SD: 0.90); Difference M: 0.70 | ||
NIC Urinary retention care (0620) (n=7) | NOC Urinary continence: Pre (M: 3.12; SD: 0.26); Post (M: 4.48; SD: 0.21); Difference M: 1.36 | ||
Sampaio et al. (2018) [14] | NANDA-I Anxiety (00146) NIC
|
Favorable effect of the NIC on the NOC score | NOC Level of anxiety (d=1.11) NOC Self-control of anxiety (d=1.65) |
Being part of the IG predicts level of anxiety | 22.8% (R2 adjusted: 0.228) Posttest (F (1.58)=18.40); p<0.001 |
||
Moderate positive association between the variable “group” and the NOC Level of anxiety total score (1211) (posttest) | Β=0.49 | ||
Being part of the IG predicts self-control of anxiety | 40% (R2 adjusted=0.400) Posttest (F (1.58)=40.27; p<0.001) |
||
Moderate positive association between the variable “group” and total score in NOC Self-control of anxiety (posttest) | Β=0.64 | ||
NOC Level of anxiety (1211): Mean differences by groups pre and post intervention | CG vs. IG: pretest CG (M: 34.58; SD: 8.91); pretest IG (M: 34.34; SD: 9.41); p=0.92 CG (n=31): pretest (M: 34.58; SD: 8.91); posttest (M: 45.71; SD: 12.36); p=0.001 IG (n=29): pretest (M: 34.34; SD: 9.41); posttest (M: 58.59; SD: 10.77); p=0.001 CG vs. IG: posttest CG (M: 45.71; SD: 12.36); posttest IG (M: 58.59; SD: 10.77); p=0.001 |
||
NOC Self-control of anxiety (1402): Mean differences by groups pre and post intervention |
CG vs. IG: pretest CG (M: 26.55; SD: 5.99); pretest IG (M: 27.1; SD: 4.81); p=0.70 CG (n=31) pretest (M: 26.55; SD: 5.99); posttest (M: 25.65; SD: 5.77); p=0.55 IG (n=29) pretest (M: 27.1; SD: 4.81); posttest (M: 34.21; SD: 4.57); p=0.001 CG vs. IG: posttest CG (M: 25.6; SD: 5.77); posttest IG (M: 34.21; SD: 4.57); p=0.001 |
||
Laguna-Parras et al. (2013) [27] | NANDA-I Sleep pattern disorder (00198) NIC Sleep improvement (1850) NOC Sleep (0004) |
Oviedo sleep questionnaire: Satisfaction with sleep |
(Admission) M: 3.27; SD: 1.51 (Discharge) M: 5.19; SD: 1.3 (Difference) M: 1.921; SD: 1.781; (CI: 1.71-2.12) p<0.0001 |
Oviedo sleep questionnaire: Insomnia |
(Admission) M: 23.52; SD: 9.05 (Discharge) M: 15.93; SD: 8.25 (Difference) M: -7.59; SD: 10.95 (CI: 6.31-8.86) p<0.0001 |
||
Oviedo sleep questionnaire: Hypersomnia |
(Admission) M: 5.97; SD: 3.76 (Discharge) M: 4.49; SD: 2.55 (Difference) M: -1.479; SD: 3.82 (CI: 1.03-1.92) p<0.0001 |
||
NOC Sleep (0004) |
(Admission) M: 1.36; SD: 0.56 (Discharge) M: 3.84; SD: 0.68 (Difference) M: 2.48; SD: 0.84 (CI: 2.38-2.58) p<0.0001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 MDPI (Basel, Switzerland) unless otherwise stated